SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (13352)1/15/1998 1:17:00 PM
From: squetch  Read Replies (1) | Respond to of 32384
 
>>Panretin is being tested for improvement of immunological parameters in HIV+ patients<< Henry, What results will they be looking at? Plus Pasteur Institute seems to be doing work w/ LGND compounds. Any connections?